1. Fisher B. Slack N, Katrych D, Wolmark N: Ten year follow-up results of patients with carcinoma of the breast in a co-operative clinical trial evaluating surgical adjuvant chemotherapy. Surg Gynecol Obstet 140:528–534, 1975
2. Greenspan EM, Fieber M, Lesnick G, Edelman S: Response of advanced breast carcinoma to the combination of the antimetabolite methodtrexate and alkylating agent Thio-TEPA. Mt. Sinai J Med NY 30:246–267, 1963
3. Greenspan EM: Combination cytotoxic chemotherapy in advanced disseminated breast cancer. Mt Sinai J Med NY 33:1–26, 1966
4. Cooper RG: Combination chemotherapy in hormone resistant breast cancer [abstr]. Proc Am. Assoc. Cancer Res 10:15, 1969.
5. Glass A, Wieand HS, Fisher B, et al: Acute toxicity during adjuvant chemotherapy for breast cancer: the National Surgical Adjuvant Breast and Bowel Project (NSABP) experience from 1,717 patients receiving single and multiple agents. Cancer Treat Rep 65:363–376, 1981